rash management for enfortumab vedotin
Published 3 months ago • 128 plays • Length 1:00Download video MP4
Download video MP3
Similar videos
-
1:00
who would not get enfortumab?
-
18:36
breakthrough in bladder cancer: fda approval - enfortumab vedotin pelbrolizumab with dr.tom powles
-
0:25
resectable mesothelioma #2023 #oncology #lungcancer
-
0:59
ribociclib in adjuvant hr breast cancer
-
6:32
personalized cancer treatment just got harder
-
1:25:24
mastering the art of precision in the treatment of hr early and metastatic breast cancer
-
12:46
the only metastatic cancer survivor retreat of its kind
-
1:26
what subspecialty fellowships are available for hematology oncology doctors?
-
2:09
enfortumab vedotin for bladder cancer
-
2:24
reinvigorating the immune system to find new ways to cure cancer
-
1:19
what's on the horizon for the treatment of mpns?
-
0:50
the addition of platinum compounds to standard chemotherapy for breast cancer patients
-
2:25
what is the role of medical oncology and chemotherapy in the treatment of lung cancer? | rush
-
0:54
mogamulizumab-associated rash in ctcl
-
1:57
cancer derived exosomal mir 7641 promotes breast cancer progression and metastasis
-
1:01:01
subtype-specific breast cancer risk in highly indigenous latin american women - laura fejerman
-
1:26
herbert newton, md - hematology and oncology
-
1:18
the role of enfortumab vedotin in urothelial cancer treatment
-
0:56
risk factors for breast cancer with dr. abolghasemi
-
1:58
croix fossum, md — radiation oncology
-
1:24
novel immunotherapies for colorectal cancer
-
1:41
meet hematologist/oncologist joseph alvarnas, m.d. | city of hope